Leadership

Board of Directors

MD & CEO

Sanjiv Navangul
Bharat Serums & Vaccines Leadership - MD & CEO of BSV - Sanjiv Navangul
Sanjiv Navangul has led global pharmaceutical companies to success by mentoring and cultivating a values-driven culture. He has served on the board of Johnson & Johnson Pvt Ltd. India and Fulford India. He has held several leadership roles, including those of Managing Director for Janssen (Pharmaceutical Division of Johnson & Johnson) in India and South Asia; Managing Director for MSD Pharmaceuticals, Philippines; and Commercial Director for MSD India and South Asia. He served as the Vice President of OPPI (Organisation of Pharmaceutical Producers of India) from 2014 to 2019 and was Chairman of the AMCHAM Pharma committee (American Chamber of Commerce) from 2016 to 2019.

Under his leadership, BSV has been ranked 41st amongst Top Companies by AIOCD AWACS in Sept 2020 and one of the Top 10 Biopharma Companies in India (Biospectrum & ABLE).

In 2022, Sanjiv was awarded CEO of the Year at the 8th ILSC Awards. In 2021, he was honored with the Maharashtra Achievers Awards for his outstanding contribution to healthcare and pharma. And in 2020, he was recognized as one of Asia's top 25 healthcare technology CEOs by The Healthcare Technology CEOs of Asia. Sanjiv is a recipient of a number of industry awards on Public Health, Marketing and Diversity. Recently he was recognized as "Impactful CEO of the Year 2023" by The Economic Times.
Read More

Director

Rajeev Juneja
Rajeev Juneja, MD and Vice Chairman of Mankind Pharma is a first-generation entrepreneur who dropped out of college in the pursuit of gaining practical experience in the pharmaceutical industry. Ever since, he describes himself as a student in the school of life. After spending 11 years understanding the intricacies and dynamics of the market, he started Mankind Pharma along with his elder brother, Shri Ramesh Juneja, in 1995.

29 years later, Mankind stands as India's premier pharmaceutical company in terms of prescriptions. Throughout this transformative period, Rajeev Juneja has passionately led diverse functional areas of business and in the process created a great balance between systems, processes and people within Mankind.
A believer in the power of simplicity, coupled with his distinctively imaginative and down-to-earth leadership style, and profound personal understanding of the customer’s needs has shaped the Mankind proposition in the market. Fueled by his heart and an unwavering commitment to fulfilling needs, Rajeev has seamlessly channeled his expertise across various organizational domains to formulate enduring, victorious strategies for the delivery of premium-quality pharmaceuticals. As a leader who recognizes the potential in each individual, he excels not only in building cross-functional teams that outperform global standards, but also in crafting and executing a compelling vision – to place Mankind Pharma among the top three companies with a strong market presence in OTC and FMCG segments.
Read More

Director

Sheetal Arora
Sheetal Arora, Chief Executive Officer of Mankind Pharma Ltd., is the visionary behind several innovative ideas and strategic decisions that have helped the company scale new heights. He is one of the trailblazers behind Mankind Pharma’s success who follows a simple ideology of 'reaching for the stars while staying firmly grounded,' which serves as an inspiration to the team of young, aspiring executives he leads.

His leadership has been a driving force in Mankind's expansion onto the global stage within the pharmaceutical industry. His strategy is to achieve the right blend of generic and niche products for global markets and nurture a team of professionals who can implement his vision.
Read More

Director

Arjun Juneja
Arjun Juneja joined Mankind Pharma Limited in 2009. He is a dedicated and accomplished business leader with a career spanning over a decade in the pharmaceutical industry. As the Chief Operating Officer at Mankind, he oversees critical areas of the business, including Research & Development, Manufacturing, Supply Chain, Quality Assessment, Information Technology & Digitization and Active Ingredients, among others.

A second-generation leader, he embodies a commitment to innovation and the relentless pursuit of new horizons. His visionary thinking and adaptability to change have been instrumental in propelling the Company to unprecedented success. Under his leadership, Mankind has achieved several milestones in the field of Operational Excellence in its Manufacturing Processes. He also led the successful listing of Mankind during the year 2023. Mankind’s IPO was the largest IPO of the calendar year 2023.

Arjun Juneja boldly expanded Mankind's reach into the US market, implementing an aggressive pricing strategy to establish the Company among India's top-tier generic pharmaceutical firms. His strategic vision has also led the Company into regulated markets, culminating in the attainment of USFDA approvals, a testament to the unwavering pursuit of the Company's vision.
Read More

BSV Leadership Team

MD & CEO

Sanjiv Navangul
Bharat Serums & Vaccines Leadership - MD & CEO of BSV - Sanjiv Navangul
Sanjiv Navangul has led global pharmaceutical companies to success by mentoring and cultivating a values-driven culture. He has served on the board of Johnson & Johnson Pvt Ltd. India and Fulford India. He has held several leadership roles, including those of Managing Director for Janssen (Pharmaceutical Division of Johnson & Johnson) in India and South Asia; Managing Director for MSD Pharmaceuticals, Philippines; and Commercial Director for MSD India and South Asia. He served as the Vice President of OPPI (Organisation of Pharmaceutical Producers of India) from 2014 to 2019 and was Chairman of the AMCHAM Pharma committee (American Chamber of Commerce) from 2016 to 2019.

Under his leadership, BSV has been ranked 41st amongst Top Companies by AIOCD AWACS in Sept 2020 and one of the Top 10 Biopharma Companies in India (Biospectrum & ABLE).

In 2022, Sanjiv was awarded CEO of the Year at the 8th ILSC Awards. In 2021, he was honored with the Maharashtra Achievers Awards for his outstanding contribution to healthcare and pharma. And in 2020, he was recognized as one of Asia's top 25 healthcare technology CEOs by The Healthcare Technology CEOs of Asia. Sanjiv is a recipient of a number of industry awards on Public Health, Marketing and Diversity. Recently he was recognized as "Impactful CEO of the Year 2023" by The Economic Times.
Read More

Chief Operating Officer (COO) - International Business

Rahul Adakmol
Rahul Adakmol - COO, International Operations - BSV
Rahul Adakmol is a visionary leader with over 15 years of experience in specialty drugs, P&L management, BD, and licensing.

He brings a pioneering perspective to our commercial and business operations subsidiaries in Germany and the Philippines, as well as our global BD and M&A.

Chief Operating Officer (COO) - India Business

Sivani Sarma Deka
A versatile business leader with diverse experience spanning over two decades, Sivani drives the vision and strategic growth of BSV’s India Business.

Prior to BSV, Sivani was Group Business Unit Head for Urology and Oncology business at Sun Pharma where she has spent over 14 years. In the past, Sivani has been associated with Glenmark, Ranbaxy and Nicholas Piramal. During her career, she has successfully managed and grown diversified portfolios across various specialties in both Indian Branded generics as well as Innovator brands. She has been serving the industry as a growth catalyst and thrives in developing and adapting business models in response to evolving market needs.

Sivani has completed her PGDBA from the Institute of Management Education, Pune, Maharashtra. An advocate of the ‘Coaching Culture’, Sivani is passionate about developing talent and inspiring teams to perform and excel.
Read More

Sr. President - R&D

Dr. Jaby Jacob
Dr. Jaby Jacob - Sr President of Research & Development of BSV

Dr. Jaby Jacob has worked at several large companies, including Kemwell Biopharma, Dr. Reddy’s and AMGEN before joining BSV.

He is an active participant in the development of several biopharmaceutical products, including monoclonal antibodies. He has over two decades of experience in developing biosimilar drug strategies for both regulated and emerging markets, including process characterization, analytical development and validation, and technology transfer management.

Chief Medical Officer

Dr Swashraya Shah
Dr. Swashraya Shah - Chief Medical Officer of BSV

Dr. Swashraya Shah has a strong background in the medical field, with a track record of success in strategic planning, team development, coaching, medico-marketing, clinical research, and regulatory sciences. A seasoned medical professional, he is skilled in identifying key challenges and implementing innovative solutions that have resulted in measurable growth and positive outcomes for companies he has worked with over the years.

Owing to his impeccable efforts BSV is ranked among the 10 Most Trusted Vaccine
Solution Providers 2020 (CIOLook Magazine).

Chief Human Resources Officer

Nilesh Kulkarni
BSV Chief Human Resources Operations - Nilesh Kulkarni

Nilesh Kulkarni is a seasoned human resources leader with over two decades of experience in L&D, recruitment, mergers and acquisitions, organization design, succession, and talent management. He has held various leadership positions in India, South Asia, and Switzerland. From being an organization driven by function, Nilesh is instrumental in making BSV an organization that’s driven by talent. His acumen has helped BSV get recognized as ‘Best Organization for Women’ by The Economic Times in 2022, ‘Best Sustainable Business Organisation’ by ET Edge in 2022, and ‘Dream Companies to Work For’ by the World HRD Congress-Feb 2019.

Head - Global Policy & Access

Chirag Mehta

Chief Financial Officer - Chirag Mehta - Bharat Serums & Vaccines

Chirag has previously worked with Cipla, Maneesh Pharma, and Intas Pharmaceuticals.

Chirag Mehta brings over two decades of experience in Finance and Operations Management, including Corporate Accounting, National Pharmaceutical Pricing Authority (NPPA), Commercial, Legal, and Central Data Management. His experience and willingness to help and motivate others has been instrumental in the success we’ve had since he joined.

He was most recently recognized by CEO Insights as one of the Top 10 CFOs of 2022.

Sr. President - Corporate Projects and Supply Chain

Anil Damle
Anil Damle - Sr. President, Corporate Projects & Supply Chains of BSV

Anil Damle has over 30 years of experience in Treasury and Risk Management, Statutory/Internal/Forensic/SOX audits, and Compliance Execution and Training. In particular, he has a strong understanding of treasury operations in a complex global environment with multiple regulatory regimes.

His contribution has helped BSV win multiple accolades, which include – ‘Best Pharma Distribution Network Strategy’ (TATA Strategic Management Group & CNBC TV18, Feb 2018), ‘Best In-Class Distribution Network Strategy’ award at the Future Supply Chain (7th Cold Chain Strategy Summit, June 2018), and ‘Best Procurement Company of the Year’ Award (IPLA 2022).

Vice President – Medical Affairs

Dr. Pratik Shah
Dr. Pratik Shah leads BSV’s Medical Affairs function. In his role, he is responsible for strengthening business and product strategies across India and international markets. During his tenure at BSV, Dr. Shah has been instrumental in building BSV’s Women’s Health portfolio through several successful medico-marketing initiatives. With his extensive experience in Pharmaceutical Medicine and Medical Affairs, Regulatory affairs, Clinical Research and Pharmacovigilance, he continues to shape medical strategies and build strong clinical, academic and industry collaborations.

Before joining BSV, he has served in leadership roles at Lupin, Astellas, and Johnson & Johnson and has gained valuable experience across several therapy areas such as oncology, transplantation, and nephrology.
A published author in peer-reviewed journals and he has been an invited speaker and moderator at numerous national and international medical and pharmaceutical conferences.

Dr. Shah holds an M.Sc. in Pharmaceutical Medicine from Hibernia College, Ireland, and an M.D. in Pharmacology from T.N. Medical College and BYL Nair Hospital, Mumbai. He also holds postgraduate diplomas in Pharmaceutical Management and Clinical Research & Trial Management.
Read More

Vice President - Legal and Secretarial

Anupama Pai

Anupama Pai is a distinguished legal professional with over 20 years of expertise across Corporate Secretarial, Legal, Corporate Governance, Risk Management, Investigation, M&A and Compliance. She leads with a collaborative spirit, a strong moral compass, and a commitment to evolving through continuous learning.

Associated with BSV since 2020, Anupama leads the Legal and Secretarial function and is responsible for Mergers & Acquisition, Statutory Compliance, Board & Shareholder management and Litigation and Non-litigation.

Her career journey includes impactful roles at WNS Global Services, MSD Pharmaceuticals, Organon India, ICICI Bank Limited, Merck Limited and Mehta Group. Her commitment to excellence has been recognized with honours like the Legal Excellence Award and Women in Law Excellence Award.

Vice President - Finance

Sai Subba Rao. J

Sai Subba Rao. J is a strategic finance leader with over 12 years of experience across business and corporate finance. With a strong commercial acumen and global perspective, Sai has led critical initiatives in multi-regional commercial finance, mergers & acquisitions, business development, NPPA-aligned pricing, and enterprise-wide cost and process optimization.

Sai has been with BSV since 2020 and oversees the finance function where he leads initiatives that drive value creation and sustainability. His key focus remains on positioning and building the financial health of the organization for long-term growth. During his tenure, he has also been an integral part of the private equity-led transformation.

Prior to BSV, Sai held senior roles at Cipla, where he has executed high-impact programs and contributed to key financial strategies across both domestic and international markets.

President - Manufacturing Operations

Lakhiram Petwal

Lakhiram Petwal leads Manufacturing Operations and Operational Excellence at BSV. He is an expert in the development and manufacturing of recombinant therapeutic biosimilars, monoclonal antibodies, biologicals, and various NDDS Parenteral Products.

Instrumental in scaling up complex biologics and ensuring compliance with global regulatory standards, Lakhiram with his signature hands-on leadership style, combines technical acumen with operational rigor. This creates an evolving culture of high performance and continuous improvement.

Lakhiram’s illustrious 25-year career blends innovation, compliance, and operational efficiency, enabling the organisation to address the growing global healthcare needs. He has previously held key operational roles at Cipla, Famycare, Flamingo, and Emerck (India). He holds a bachelor’s degree in pharmacy.

President - Quality

Dr. Sanjeeb Mishra

Dr. Sanjeeb Mishra oversees quality functions at BSV, ensuring compliance with global regulatory standards and product excellence. At BSV, he oversees the quality function, ensuring products meet global regulatory standards and the highest levels of safety and efficacy.

With a vast and valuable experience of over 25 years, Dr. Mishra has led quality and compliance at leading pharmaceutical organizations such as Zydus Cadila, FDC, IPCA, and Aristo. He is considered an industry expert in GMP, regulatory audits, and quality systems implementation.

Dr. Mishra holds a postgraduate degree in Pharmaceutical Technology and a Ph.D. in Pharmaceutical Sciences. At BSV, he champions a quality-first culture across the product lifecycle.

Vice President – Commercial Excellence

Arun Chandran

Arun Chandran brings over a decade of diverse experience across strategy, transformation, and P&L management in the pharmaceutical industry.

Arun has been a part of BSV since 2020 and currently heads the Commercial Excellence, where he drives business performance and execution rigor. Prior to this, he has held progressive leadership roles in which he has set up the Transformation & Strategy Office, led the sales for one of BSV’s domestic divisions, to name a few.

Before BSV he has worked internationally with pharma major, Sandoz, in their global headquarters, and began his career as a management consultant with Kearney. Arun has an MBA from IIM Calcutta and holds a B.Tech & M.Tech degree from IIT Madras.

Sustainability and Corporate Social Responsibility Committee

Bharat Serums & Vaccines Leadership - MD & CEO of BSV - Sanjiv Navangul
Mr. Sanjiv Navangul
Image
Mr. Rajeev Juneja
Image
Mr. Sheetal Arora
Image
Mr. Bharat Anand